Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07360249
NCT07360249RecruitingNot Applicable

PILOT TEST OF GLUCOSE-FRUCTOSE RATIOS ON EXOGENOUS CARBOHYDRATE OXIDATION RATES DURING EXERCISE

University of Bath0 sites10 target enrollmentStarted: January 14, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
10
Study OverviewStudy DesignEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim of this pilot study is to estimate the effect size of changing the glucose-fructose ratio from 1:0.5 to 1:1 on exogenous carbohydrate oxidation rates during exercise, which can be used to power a future definitive study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age: 18 years and above;
  • •Performing endurance training for at least 5 hours per week
  • •Capable of three hours of continuous exercise

Exclusion Criteria

  • •Glucose or lipid lowering, or weight loss medication
  • •Diagnosis of cardiovascular disease, renal failure, liver disease or type 2 diabetes
  • •Contraindications to exercise
  • •Pregnant or lactating

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Javier Gonzalez

Professor of Nutrition and Metabolism

University of Bath

Similar Trials

Completed
Phase 1
A Phase I, Single-Centre, Double-Blind, Randomized, Placebo-Controlled Clinical Trial To Determine Urinary Xylose Cut-Off Point For The Diagnosis Of Hypolactasia, After A Single Dose Of Gaxilose in Children Between 5 – 11 Years Of Age.
2023-504232-18-00Venter Pharma S.L.18
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR)
2024-513562-19-00Iperboreal Pharma S.r.l.155
Not yet recruiting
Phase 1
Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets
NCT07300059Aspargo Labs, Inc24
Completed
Not Applicable
Pilot study to investigate glucose concentrations in people without diabetes mellitus during oral glucose tolerance test (oGTT)E14Unspecified diabetes mellitus
DRKS00026765Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT)42
Recruiting
Not Applicable
Exercising in Hot Conditions: How Does it Effect Blood Glucose in People With T1D
NCT07341243Liverpool John Moores University38